SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001140361-23-021557
Filing Date
2023-04-28
Accepted
2023-04-28 16:15:58
Documents
14
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A brhc20051875_10ka.htm   iXBRL 10-K/A 483725
2 EXHIBIT 31.3 brhc20051875_ex31-3.htm EX-31.3 6257
3 EXHIBIT 31.4 brhc20051875_ex31-4.htm EX-31.4 6572
  Complete submission text file 0001140361-23-021557.txt   749490

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20221231.xsd EX-101.SCH 3871
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20221231_lab.xml EX-101.LAB 31040
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20221231_pre.xml EX-101.PRE 21949
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc20051875_10ka_htm.xml XML 7134
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37568 | Film No.: 23866429
SIC: 2834 Pharmaceutical Preparations